Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Stem Cell Innovations to provide research and assay services to Agennix
April 2010
SHARING OPTIONS:

HOUSTON—Stem Cell Innovations, a cell biology company, announced in March that it has signed an agreement to provide research and assay services to Agennix AG, a publicly traded biopharmaceutical company. The agreement will support of Agennix's talactoferrin program. The assay utilizes Stem Cell Innovations' C3A human liver cell line. Stem Cell Innovations will provide other research and cell culture services to Agennix. Further details were not disclosed.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.